Welcome to Team Genus
Asset Allocation & Portfolio Management Tools for Investors
 
  • Welcome : Guest
  • Icon
 
About Team Genus Post your feedback Client Registration
Your Current Location : Fund Card : Fund Summary
 
Baroda BNP Paribas Ultra Short Duration Fund (G)
[Debt: Ultra Short Duration]
Other Options
 
Fund Details
Fund Type Growth Launch Date 24 May 2018
Corpus(Cr.) 1045.0 Scheme NAV 1468.27
Equity(%) 0.0 52 Week High 1468.27
Debt(%) 99.74 52 Week Low 1367.04
Others(%) 0.26 Exit Load 0
Minimum Investment - Availability Open
Entry Load - Expense Ratio(%) 0.48
Scheme Benchmark CRISIL Ultra Short Term Debt Index Broader Benchmark CRISIL 1 Year T-Bill Index
 
Scheme Objective
The scheme seeks to generate regular income by investing in a portfolio of debt and money market instruments such that the Macaulay duration of the portfolio is between 3 months 6 months. A Relatively Low Interest Rate Risk and Moderate Credit Risk
 
 
 
 
useful links Reserve Bank of India
 
FUNDS : 360  |  Aditya  |  Axis  |  Bajaj  |  Bandhan  |  Bank  |  Baroda  |  Canara  |  DSP  |  Edelweiss  |  Edelweiss  |  Franklin  |  Groww  |  HDFC  |  Helios  |  HSBC  |  ICICI  |  Invesco  |  ITI  |  JM  |  Kotak  |  LIC  |  Mahindra  |  Mirae  |  Motilal  |  NAVI  |  Nippon  |  NJ  |  Old  |  PGIM  |  PPFAS  |  Quant  |  Quantum  |  Samco  |  SBI  |  Shriram  |  Sundaram  |  Tata  |  Taurus  |  TRUST  |  Union  |  User  |  UTI  |  WhiteOak  |  Zerodha  | 
 

Disclaimer: While all efforts have been taken to make this web site as authentic as possible, Team Genus Financial Services Private Limited (www.teamgenus.in) will not be responsible for any loss to any person/entity caused by any short-coming; defect or inaccuracy inadvertently or otherwise crept in the teamgenus.in web site. Mutual Fund Investments are subject to market risks, read all scheme related documents carefully before investing into Mutual Funds. The use of information and services is subject to the terms and conditions governing this website.

Follow Us on
Design & Developed by : InvestWell